Overall, increased CRP in metabolic syndrome patients increases the likelihood of cardiovascular events (CVE) by its impact on vascular cells, especially monocyte activation and the formation of endothelial cell dysfunction. This evidence concerns the gene CRP and metabolic syndrome.